Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions

Insulin Resistance

Interventions

DRUG

Intralipid, 20% Intravenous Emulsion

Lipid infusion

DIETARY_SUPPLEMENT

MitoQ

Oral administration of MitoQ capsules

DRUG

Salbutamol

Beta2-agonist infusion

Trial Locations (1)

August Krogh Building, Copenhagen

All Listed Sponsors

lead

University of Copenhagen

OTHER

NCT04558190 - Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle | Biotech Hunter | Biotech Hunter